Home▸Schizophrenia & Autism Spectrum Treatment▸Tardive Dyskinesia & EPS Risk Simulator

🧩 Tardive Dyskinesia & EPS Risk Simulator

This simulator assesses the risk of tardive dyskinesia and extrapyramidal symptoms in patients with prolonged antipsychotic use, using the AIMS scale and comparing typical and atypical medications.

Schizophrenia & Autism Spectrum Treatment2DModerate60 FPS
tardive-dyskinesia-eps-risk-simulator ↗ Open standalone

Acute Extrapyramidal Symptoms

Short placeholder sentence on acute dystonia and parkinsonism.

  • Hours–weeks: Onset window (Placeholder short caption)
  • Dystonia: Common signs (Placeholder short caption)
  • D2 blockade: Mechanism (Placeholder short caption)
  • Higher/Lower: Typical vs atypical (Placeholder short caption)

Acute reaction mechanisms

Placeholder short paragraph on acute EPS mechanisms and presentation.

Chronic Dopamine Receptor Supersensitivity

Short placeholder sentence on D2 receptor upregulation over years.

  • D2 upregulation: Receptor change (Placeholder short caption)
  • Months–years: Timeframe (Placeholder short caption)
  • Chronic blockade: Driver (Placeholder short caption)
  • Supersensitivity: Outcome (Placeholder short caption)

Supersensitivity hypothesis

Placeholder short paragraph on receptor supersensitivity theory.

Tardive Dyskinesia Onset

Short placeholder sentence on lip smacking and tongue protrusion onset.

  • Orofacial: Hallmark signs (Placeholder short caption)
  • ~Years-linked: Cumulative risk (Placeholder short caption)
  • Higher risk: Typical drugs (Placeholder short caption)
  • Lower risk: Atypical drugs (Placeholder short caption)

Movement pattern development

Placeholder short paragraph describing progressive movement patterns.

AIMS Scale Assessment

Short placeholder sentence on the Abnormal Involuntary Movement Scale.

  • 0–40: Scale range (Placeholder short caption)
  • Face/limb/trunk: Domains scored (Placeholder short caption)
  • Every 3–6mo: Screening interval (Placeholder short caption)
  • Track severity: Purpose (Placeholder short caption)

AIMS scoring approach

Placeholder short paragraph on AIMS scoring procedure.

Typical vs Atypical Antipsychotic Comparison

Short placeholder sentence comparing long-term EPS/TD burden by drug class.

  • ~5%: Typical TD/yr (Placeholder short caption)
  • ~1%: Atypical TD/yr (Placeholder short caption)
  • Declines w/ time: Reversibility (Placeholder short caption)
  • Lower dose/switch: Clinical takeaway (Placeholder short caption)

Comparative long-term risk

Placeholder short paragraph comparing drug classes over time.

Placeholder short key-insight sentence on minimizing cumulative TD risk.
⚙ Under the hood

This simulator assesses the risk of tardive dyskinesia and extrapyramidal symptoms in patients with prolonged antipsychotic use, using the AIMS scale and comparing typical and atypical medications.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)